Selected Grants
The Post-Lung Transplant Impact of Alveolar Macrophage Senescence in Aged Donor Lungs
ResearchPrincipal Investigator · Awarded by National Institutes of Health · 2025 - 2030Fellowships, Gifts, and Supported Research
Targeted Ex vivo Nanotherapy for use in Cardiac Transplantation ·
2017
- 2019
Primary Investigator ·
Awarded by: American Heart Association
· $110,456.00
17CPOST3367120. Utilized micellar rapamycin nanoparticles targeted to coronary endothelium during static cold storage to ameliorate ischemia-reperfusion injury post transplantation.
Amelioration of Cardiac Transplant Vasculopathy Using Targeted Ex Vivo Nanotherapy ·
2015
- 2017
T32 Postdoctoral Fellow ·
Awarded by: National Institute of Health; National Heart, Lung, and Blood Institute
· $100,000.00
NIH-HL-007260. Utilized micellar rapamycin nanoparticles targeted to coronary endothelium during static cold storage to delay the onset of chronic rejection and cardiac allograft vasculopathy.
External Relationships
- United Therapeutics Corp.
This faculty member (or a member of their immediate family) has reported outside activities with the companies, institutions, or organizations listed above. This information is available to institutional leadership and, when appropriate, management plans are in place to address potential conflicts of interest.